A bivalent CMV vaccine formulated with human compatible TLR9 agonist CpG1018 elicits potent cellular and humoral immunity in HLA expressing mice. - Dasari, Vijayendra; Beckett, Kirrilee; Horsefield, Shane; Ambalathingal, George; Khanna, Rajiv (PLoS Pathogens, 2022)